CARRTECH APPROVED AS A QMBC (QUALIFIED MARYLAND BIOTECHNOLOGY COMPANY)

Written By Sue Carr

CARRTECH APPROVED AS A QMBC (QUALIFIED MARYLAND BIOTECHNOLOGY COMPANY)

As a QMBC, CarrTech received the Biotechnology Investment Incentive Tax Credit (BIITC), receiving income tax credit equal to 50% of an eligible investment in a Qualified Maryland Biotechnology Company (QMBC). Read more.

Sue Carr

Sue Carr President and founder of CarrTech has been a pharmacist both in retail and hospital management for over 30 years. She saw a problem with the inefficiency and safety of filtering and came up with a solution called FROG, Filter Removal of Glass and founded CarrTech. Currently CarrTech is preparing for FDA approval in 2022.

http://www.carrtechcorp.com
Previous

Q4 2021 CARRTECH NEWSLETTER
Next

CARRTECH RECIEVES FINANCIAL INVESTMENT AND SUPPORT FROM OLD LINE CAPITAL PARTNERS